Maximum Diabetes Patients Onboarded In A Real-World Evidence Study

Lupin Limited, Mumbai, India, set the record for the maximum number of diabetes patients onboarded in a real-world evidence (RWE) study. A total of 67,802 patients were enrolled across 1,336 clinics in the real-world evidence study conducted for vildagliptin and its combinations. This study collected crucial data on demographics, disease duration, laboratory investigations, and treatment outcomes, providing valuable insights into real-world diabetes management. as confirmed on March 6, 2025.